Member Info for Harrogate4

B2HS2L --------- "of the basket case investor relations scenario which is ICR."

Sad but true, can't think why they ever engaged them.

Serendipidity -------Anyone know why AIM always lags the ASX price slightly?

No, it's one of life's mysteries -----but am sure that some on here can explain it.

Lovely Jubbly as Del would say ---- this time next year Rodders --we'll all be millionaires.

HarChris -----"He clearly knows what he’s talking about."

Agree, and I always find his views interesting and well written.

We have all got things wrong at times on timescales etc with Avacta but these errors are reducing under CC's effective leadership.

Very much looking forward to developments over the next few weeks.

Bella ----Agree

Silence may be golden, but it butters no parsnips.

AvctIPmatters -----------Obviously prefer this view on Avacta .

Much better!

Can't help but note that if you talk at present to many cancer consultants and specialists around the country, you will find that most of them have never heard of Avacta or the Precision delivery advances for chemo that they are progressing.

Time for a bit of MSM publicity?

Amazed Avacta has not sorted this.

AvctIPmatters --------"Nothing new rather somber summary :"

I would describe the summary as "balanced" rather than "sombre "

AvctIPmatters ----------fyi ********************28jo8l9u

Any further information would be welcome.

It's a pure guess but I am presuming CC's loyalties do not reside with Trump and the Republicans.

------is the title of an article on the front page of today's Times Business Section by Alex Ralph the Chief Business Correspondent.

In essence, big US pharma companies will be under orders from Trump to not only cancel future investments in the UK but also shut down their facilities in the UK., ie firms such as Eli Lilly, Johnson & Johnson, Bristol Myers Squibb etc. Trump wants the UK to pay more for some US made medicines in exchange foe a deal on tariffs and the exodus is his leverage presumably.

Should make the case for dealing with Novartis even stronger I would have thought, or other (more stable and trustworthy) partners.

About time for a breakthrough to 90 plus ----been faffing round sub 90 for so long now.

Thorn -------"-Might be my best Christmas ever?"

I hope it is as well, for you, for the patients and for all the LTHs of Avacta.

Thorn --------"Sorry Harrogate I just don't see it."

You are pushing at an open door Thorn.

I am in agreement mainly with your view regarding a successful future for Avacta.

Some people however see things differently and may need their nerves to be calmed.

I was merely pointing that out.

Is that clear?

Thorn -------"-Why would nerves 'need calming'?"

Because people differ in how they react to news---obviously.

AvctIPmatters ---------"Just a matter of time : Listen to yesterday CEO snippet ( thanks TTB )"

Must agree, that's a great inspiring clip from CC and may assist calming a few nerves.

Jmfw " The CEO is saying they will always be interested in new/disruptive technologies."

Well here it is, so get in fast ----and get somebody more able to write unconfusing the headline articles.

It's not a good look for a big pharma.

Jmfw --------The headline is somewhat misleading as it leaves out 'Novartis'

.

Exactly, it's confusing and not well drafted

Here is the headline by the way:

Novartis CEO says pharma giant has the firepower for big M&A deals: ‘Can never be done’

Jmfw Am I alone in thinking that the headline is somewhat confusing for this Novartis article?

AvctIPmatters ------Courtesy AL X tweet

This person can certainly turn a phrase, a very gifted poster. Hope they are correct -----they seem to know what they are on about.